This project will commercialize bioprinted tissue therapeutics, expand AI-enabled bioprinting and cell engineering capabilities, and establish a commercial-scale Current Good Manufacturing Practice bi...
Aspect Biosystems Ltd.
26 enregistrements totalisant 146,510,207.00 $ CAN, selon les données ouvertes officielles du gouvernement du Canada.
Intégrer ce graphique
Par ministère
| Innovation, Sciences et Développement économique Canada | $128,000,000 | 2 enregistrements |
| Développement économique Canada pour le Pacifique | $7,163,299 | 2 enregistrements |
| Diversification de l'économie de l'Ouest Canada | $6,435,388 | 3 enregistrements |
| Conseil national de recherches Canada | $4,890,242 | 17 enregistrements |
| Affaires mondiales Canada | $21,278 | 2 enregistrements |
Enregistrements
Project Podium: Establish a world-leading biomanufacturing facility & capabilities to advance and produce bioprinted tissue therapeutics in Canada
Increase sales of bioprinter technology services through improved business processes
Increase sales of bioprinter technology services through improved business processes
Commercialize an innovative 3D bioprinting platform for manufacturing human tissue
Commercialize an innovative 3D bioprinting platform for manufacturing human tissue
Support Aspect Biosystems Ltd. to continue operations during the COVID-19 pandemic
This project will support the firm to achieve key development and regulatory milestones for their bioprinted pancreatic tissue therapeutic for Type 1 Diabetes to advance to final IND-enabling studies,...
This project will involve the development of novel 3D printing technologies (including hardware, software, biomaterials, and methods) to enable the fabrication of implantable tissues that can engraft...
CIIP Korea project 3D Printing Therapy will integrate unique 3D bioprinting technology from Aspect Biosystems Ltd. (Canada) with pluripotent stem cell technology from NEXEL Co., Ltd. (Korea) and tissu...
This project involves the development of scalable manufacturing processes and improved automation systems for the firm's novel microfluidics-based 3D bioprinter platform that are necessary for the suc...
This international collaborative project integrates innovative Canadian bioprinting technology with unique cell immortalization and tissue technology from Germany in order to generate and validate a p...
The proposed CanExport project addresses Aspect Biosystems’ international growth strategy of our microfluidic 3D bioprinting technology through market awareness and partnerships in targeted regions of...
The purpose of this CanExport SMEs agreement is to support small- and medium-sized enterprises (SMEs) for activities related to export market development that are part of an export business case for a...
This Youth project will provide employment for a recent graduate in the role of a production analyst for novel microfluidic devices.
Carbon Connect is an innovative, emissions management service package providing oil and gas producers with compliance systems, strategies and implementation of Canadian emissions reduction technologie...
Subsidy payments to industry for research and deve